BioLife Research Development vs Cost Of Revenue Analysis

BLFS Stock

USD 26.77 0.76 2.92%

BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions Research Development and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions Research Development account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between BioLife Solutions' Research Development and Cost Of Revenue is 0.97. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' Research Development and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of BioLife Solutions are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Research Development i.e., BioLife Solutions' Research Development and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Cost Of Revenue

Cost of Revenue is found on BioLife Solutions income statement and represents the costs associated with goods and services BioLife Solutions provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 753.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 52.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	68.1M	93.7M	117.6M	123.5M
Cost Of Revenue	81.4M	107.9M	96.5M	101.3M

Total Operating Expenses Cost Of Revenue

BioLife Solutions fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Non Current Liabilities Total	Inventory	Net Receivables	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments	Short Term Debt
Total Assets		1.0	0.98	0.59	0.99	-0.15	-0.79	0.68	0.99	0.99	0.97	0.85	0.95	-0.05	0.98	0.96	0.99	0.96	0.93	0.89	0.93	0.94	0.28	0.18	0.61	0.79
Other Current Liab	1.0		0.98	0.62	0.99	-0.16	-0.78	0.69	0.99	0.98	0.97	0.85	0.95	-0.07	0.97	0.96	0.98	0.96	0.92	0.89	0.93	0.93	0.27	0.18	0.59	0.79
Total Current Liabilities	0.98	0.98		0.52	0.99	0.02	-0.88	0.57	0.97	0.97	0.99	0.79	0.96	-0.08	0.99	0.99	1.0	0.94	0.9	0.93	0.98	0.95	0.31	0.19	0.7	0.87
Total Stockholder Equity	0.59	0.62	0.52		0.51	-0.46	-0.38	0.68	0.61	0.55	0.58	0.52	0.55	-0.03	0.57	0.46	0.51	0.53	0.34	0.37	0.55	0.3	0.1	0.1	-0.19	0.52
Property Plant And Equipment Net	0.99	0.99	0.99	0.51		-0.09	-0.83	0.65	0.98	0.99	0.97	0.85	0.96	-0.09	0.98	0.98	1.0	0.97	0.93	0.92	0.94	0.96	0.3	0.19	0.69	0.81
Net Debt	-0.15	-0.16	0.02	-0.46	-0.09		-0.23	-0.8	-0.1	-0.1	0.02	-0.54	-0.11	-0.29	-0.04	0.09	-0.02	-0.27	-0.04	0.17	0.09	0.06	0.1	0.13	0.3	0.28
Retained Earnings	-0.79	-0.78	-0.88	-0.38	-0.83	-0.23		-0.35	-0.76	-0.8	-0.87	-0.61	-0.9	-0.01	-0.9	-0.87	-0.86	-0.8	-0.64	-0.81	-0.95	-0.79	-0.33	-0.15	-0.75	-0.93
Cash	0.68	0.69	0.57	0.68	0.65	-0.8	-0.35		0.63	0.64	0.57	0.92	0.65	0.14	0.61	0.52	0.6	0.78	0.53	0.45	0.5	0.5	0.1	0.08	0.16	0.32
Non Current Assets Total	0.99	0.99	0.97	0.61	0.98	-0.1	-0.76	0.63		0.98	0.97	0.8	0.93	-0.08	0.96	0.95	0.98	0.93	0.94	0.89	0.92	0.93	0.27	0.18	0.57	0.79
Non Currrent Assets Other	0.99	0.98	0.97	0.55	0.99	-0.1	-0.8	0.64	0.98		0.95	0.82	0.95	-0.07	0.97	0.95	0.98	0.95	0.93	0.88	0.94	0.95	0.25	0.19	0.65	0.77
Other Assets	0.97	0.97	0.99	0.58	0.97	0.02	-0.87	0.57	0.97	0.95		0.77	0.94	-0.11	0.98	0.98	0.98	0.92	0.87	0.92	0.97	0.92	0.32	0.2	0.63	0.9
Cash And Short Term Investments	0.85	0.85	0.79	0.52	0.85	-0.54	-0.61	0.92	0.8	0.82	0.77		0.84	0.11	0.81	0.76	0.82	0.95	0.75	0.69	0.72	0.77	0.2	0.12	0.53	0.53
Common Stock Shares Outstanding	0.95	0.95	0.96	0.55	0.96	-0.11	-0.9	0.65	0.93	0.95	0.94	0.84		0.09	0.98	0.92	0.96	0.96	0.84	0.82	0.96	0.9	0.29	0.08	0.69	0.83
Other Current Assets	-0.05	-0.07	-0.08	-0.03	-0.09	-0.29	-0.01	0.14	-0.08	-0.07	-0.11	0.11	0.09		-0.02	-0.16	-0.09	0.04	-0.06	-0.26	-0.04	-0.03	0.03	-0.31	0.12	-0.18
Other Stockholder Equity	0.98	0.97	0.99	0.57	0.98	-0.04	-0.9	0.61	0.96	0.97	0.98	0.81	0.98	-0.02		0.97	0.99	0.95	0.87	0.89	0.98	0.93	0.31	0.16	0.68	0.88
Total Liab	0.96	0.96	0.99	0.46	0.98	0.09	-0.87	0.52	0.95	0.95	0.98	0.76	0.92	-0.16	0.97		0.98	0.92	0.9	0.98	0.95	0.95	0.3	0.28	0.71	0.88
Property Plant And Equipment Gross	0.99	0.98	1.0	0.51	1.0	-0.02	-0.86	0.6	0.98	0.98	0.98	0.82	0.96	-0.09	0.99	0.98		0.96	0.92	0.93	0.96	0.96	0.31	0.19	0.71	0.85
Total Current Assets	0.96	0.96	0.94	0.53	0.97	-0.27	-0.8	0.78	0.93	0.95	0.92	0.95	0.96	0.04	0.95	0.92	0.96		0.86	0.85	0.9	0.91	0.27	0.16	0.67	0.74
Accounts Payable	0.93	0.92	0.9	0.34	0.93	-0.04	-0.64	0.53	0.94	0.93	0.87	0.75	0.84	-0.06	0.87	0.9	0.92	0.86		0.86	0.8	0.96	0.24	0.14	0.67	0.63
Non Current Liabilities Total	0.89	0.89	0.93	0.37	0.92	0.17	-0.81	0.45	0.89	0.88	0.92	0.69	0.82	-0.26	0.89	0.98	0.93	0.85	0.86		0.88	0.9	0.26	0.37	0.68	0.85
Inventory	0.93	0.93	0.98	0.55	0.94	0.09	-0.95	0.5	0.92	0.94	0.97	0.72	0.96	-0.04	0.98	0.95	0.96	0.9	0.8	0.88		0.89	0.31	0.18	0.69	0.92
Net Receivables	0.94	0.93	0.95	0.3	0.96	0.06	-0.79	0.5	0.93	0.95	0.92	0.77	0.9	-0.03	0.93	0.95	0.96	0.91	0.96	0.9	0.89		0.28	0.15	0.8	0.73
Short Long Term Debt Total	0.28	0.27	0.31	0.1	0.3	0.1	-0.33	0.1	0.27	0.25	0.32	0.2	0.29	0.03	0.31	0.3	0.31	0.27	0.24	0.26	0.31	0.28		-0.08	0.39	0.4
Common Stock Total Equity	0.18	0.18	0.19	0.1	0.19	0.13	-0.15	0.08	0.18	0.19	0.2	0.12	0.08	-0.31	0.16	0.28	0.19	0.16	0.14	0.37	0.18	0.15	-0.08		0.06	0.23
Short Term Investments	0.61	0.59	0.7	-0.19	0.69	0.3	-0.75	0.16	0.57	0.65	0.63	0.53	0.69	0.12	0.68	0.71	0.71	0.67	0.67	0.68	0.69	0.8	0.39	0.06		0.58
Short Term Debt	0.79	0.79	0.87	0.52	0.81	0.28	-0.93	0.32	0.79	0.77	0.9	0.53	0.83	-0.18	0.88	0.88	0.85	0.74	0.63	0.85	0.92	0.73	0.4	0.23	0.58

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	93.0M	234.8M	552.6M	450.2M	412.7M	433.3M
Other Current Liab	3.5M	9.1M	20.2M	15.7M	15.4M	16.2M
Total Current Liabilities	7.8M	15.6M	40.0M	44.6M	42.2M	44.3M
Total Stockholder Equity	83.0M	205.2M	480.8M	(246.9M)	337.7M	354.5M
Property Plant And Equipment Net	6.6M	19.8M	36.8M	39.2M	32.6M	34.2M
Net Debt	(5.1M)	(79.3M)	(43.0M)	24.3M	7.3M	7.6M
Retained Earnings	(100.1M)	(97.4M)	(105.0M)	(246.9M)	(313.3M)	(297.7M)
Cash	6.4M	90.5M	69.9M	19.4M	35.4M	37.2M
Non Current Assets Total	68.8M	120.1M	426.7M	311.8M	292.1M	306.7M
Non Currrent Assets Other	3.9M	4.7M	9.8M	9.3M	8.0M	8.4M
Other Assets	50K	120.1M	426.7M	386.2M	444.1M	466.3M
Cash And Short Term Investments	6.4M	90.5M	69.9M	64.1M	51.7M	54.3M
Common Stock Shares Outstanding	19.5M	27.3M	38.5M	42.5M	43.7M	45.9M
Liabilities And Stockholders Equity	93.0M	234.8M	552.6M	(160.9M)	412.7M	433.3M
Other Current Assets	13.1M	4.7M	4.7M	6.9M	6.8M	3.6M
Other Stockholder Equity	183.1M	302.6M	585.4M	611.7M	651.3M	683.9M
Total Liab	10.0M	29.6M	71.9M	86.0M	75.1M	78.8M
Property Plant And Equipment Gross	6.6M	19.8M	43.5M	48.4M	42.1M	44.2M
Total Current Assets	24.2M	114.7M	125.9M	138.5M	120.6M	126.6M
Accounts Payable	3.1M	3.7M	14.9M	15.4M	6.9M	7.3M
Non Current Liabilities Total	2.2M	14.0M	31.9M	41.5M	32.9M	34.5M
Inventory	11.1M	11.6M	28.3M	34.9M	43.5M	45.6M
Net Receivables	5.3M	8.0M	23.2M	33.9M	18.7M	19.6M
Common Stock Total Equity	14.0K	19K	21K	33K	38.0K	35.1K
Common Stock	21K	33K	42K	43K	45K	36.6K
Property Plant Equipment	1.3M	5.6M	24.5M	46.6M	53.6M	56.3M
Other Liab	41.1M	14.0M	31.9M	2.6M	3.0M	2.8M
Net Tangible Assets	(12.2M)	205.2M	480.8M	364.2M	418.8M	439.8M
Retained Earnings Total Equity	(74.0M)	(71.0M)	(100.1M)	(97.4M)	(87.6M)	(92.0M)
Capital Surpluse	84.0M	114.2M	143.5M	302.6M	348.0M	365.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC